Warning: The NCBI web site requires JavaScript to function. more...
Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?
Sedo A, Duke-Cohan JS, Balaziova E, Sedova LR.
Arthritis Res Ther. 2005;7(6):253-69. Epub 2005 Oct 26. Review.
Related citations
Peptide truncation by dipeptidyl peptidase IV: a new pathway for drug discovery?
Scharpé S, De Meester I.
Verh K Acad Geneeskd Belg. 2001;63(1):5-32; discussion 32-3. Review.
Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
Mizokami Y, Kajiyama H, Shibata K, Ino K, Kikkawa F, Mizutani S.
Int J Cancer. 2004 Jul 10;110(5):652-9.
Dipeptidyl peptidase-IV activity and/or structure homologs (DASH): contributing factors in the pathogenesis of rheumatic diseases?
Balaziova E, Sedova L, Mares V, Vlasicova K, Sevcik J, Sedo A.
Adv Exp Med Biol. 2006;575:169-74. No abstract available.
Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation.
Aertgeerts K, Ye S, Tennant MG, Kraus ML, Rogers J, Sang BC, Skene RJ, Webb DR, Prasad GS.
Protein Sci. 2004 Feb;13(2):412-21. Epub 2004 Jan 10.
Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.
Ohtsuki T, Hosono O, Kobayashi H, Munakata Y, Souta A, Shioda T, Morimoto C.
FEBS Lett. 1998 Jul 17;431(2):236-40.
Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis.
Sromova L, Mareckova H, Sedova L, Balaziova E, Sedo A.
Clin Chim Acta. 2010 Aug 5;411(15-16):1046-50. Epub 2010 Mar 31.
Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.
Busso N, Wagtmann N, Herling C, Chobaz-Péclat V, Bischof-Delaloye A, So A, Grouzmann E.
Am J Pathol. 2005 Feb;166(2):433-42.
Dipeptidyl peptidase IV (DPPIV) enzyme activity on immature T-cell line R1.1 is down-regulated by dynorphin-A(1-17) as a non-substrate inhibitor.
Gabrilovac J, Abramić M, Uzarević B, Andreis A, Poljak L.
Life Sci. 2003 May 30;73(2):151-66.
Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.
Mentlein R.
Regul Pept. 1999 Nov 30;85(1):9-24. Review.
CD26/dipeptidyl peptidase IV and its role in cancer.
Pro B, Dang NH.
Histol Histopathol. 2004 Oct;19(4):1345-51. Review.
Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion.
Lambeir AM, Durinx C, Proost P, Van Damme J, Scharpé S, De Meester I.
FEBS Lett. 2001 Nov 2;507(3):327-30. Erratum in: FEBS Lett 2002 Feb 13;512(1-3):353.
Hemorphins: substrates and/or inhibitors of dipeptidyl peptidase IV. Hemorphins N-terminus sequence influence on the interaction between hemorphins and DPPIV.
Cohen M, Fruitier-Arnaudin I, Piot JM.
Biochimie. 2004 Jan;86(1):31-7.
CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.
Iwata S, Yamaguchi N, Munakata Y, Ikushima H, Lee JF, Hosono O, Schlossman SF, Morimoto C.
Int Immunol. 1999 Mar;11(3):417-26.
Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer.
Busek P, Malík R, Sedo A.
Int J Biochem Cell Biol. 2004 Mar;36(3):408-21. Review.
Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.
Abbott CA, McCaughan GW, Levy MT, Church WB, Gorrell MD.
Eur J Biochem. 1999 Dec;266(3):798-810.
N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
Aertgeerts K, Ye S, Shi L, Prasad SG, Witmer D, Chi E, Sang BC, Wijnands RA, Webb DR, Swanson RV.
Protein Sci. 2004 Jan;13(1):145-54.
Roles of cysteines in rat dipeptidyl peptidase IV/CD26 in processing and proteolytic activity.
Dobers J, Grams S, Reutter W, Fan H.
Eur J Biochem. 2000 Aug;267(16):5093-100.
Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation.
Arscott WT, LaBauve AE, May V, Wesley UV.
Oncogene. 2009 Jan 29;28(4):479-91. Epub 2008 Nov 3.
Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog.
Rasmussen HB, Branner S, Wiberg FC, Wagtmann N.
Nat Struct Biol. 2003 Jan;10(1):19-25.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on